Home
OE Originals
OE Insights
CME
All Specialties
Arthroplasty
Cannabis
Ev. Based Medicine
Foot & Ankle
General Orthopaedics
Hand & Wrist
Metabolic Disorders
Osteoarthritis
Pediatric Orthopaedics
Peri-Operative
Phys. Therapy & Rehab
Shoulder & Elbow
Spine
Sports Medicine
Trauma
Tumour

Author Interviews

Conference Reports

PeerView

All Videos
(137 Videos)

Education
(9 Videos)
Innovation
(0 Videos)
Leadership
(3 Videos)
OrthoJoe
(16 Videos)
Other
(12 Videos)
Personal Growth
(1 Videos)
Practice
(2 Videos)
Research
(18 Videos)

COVID-19 Resource Center

OE World Tour

OE Perspectives

OE Ideas

OE Recommends

To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Loading...
Search Filters

Date Range

to

Report Types

ALL
RCT
META
ACE Reviews

Condition

Region of the Body

Specialties

See all (18)

Emerging Treatments

OE Recommends Topics

Multimedia

Journal

Conference Series

Evidence Series

We found 3 results matching your search query: "Abaloparatide"

Showing 1 - 3 of 3
Read Ace Report

AAOS2018: Abaloparatide 80ug daily reduces rate of major NVFs in osteoporotic postmenopausal women

RCT Metabolic Disorders Osteoporosis Postmenopausal Women Fracture Abaloparatide Placebo Subcutaneous Injection - Hide
Read Ace Report

WCO-IOF 2016: Daily subcutaneous abaloparatide vs teriparatide & placebo for osteoporosis

RCT Metabolic Disorders Osteoporosis Postmenopausal Women Joint Vertebral Fracture Teriparatide Abaloparatide Placebo - Hide
Read Ace Report

Subcutaneous Abaloparatide in Men with Osteoporosis

J Bone Miner Res. 2022 01-Dec;():. 10.1002/jbmr.4719

RCT General Orthopaedics Osteoporosis Axial Skeleton Spine Appendicular Lower Extremity Spine Hip Bone Femur Abaloparatide Placebo Lumbar Spine Parathyroid hormone - Hide
Showing 1 - 3 of 3